ASCP Examination Content Outline


                        I.         MOLECULAR SCIENCE (25-30%)
A.   Nucleic Acid Chemistry
1.     Sugars
2.     Bases
3.     Chemical structure
4.     Associated proteins
5.     Mutations
B.    Basic Molecular Theory
1.      Replication
2.      Transcription
3.      Exons, introns, and splicing
4.      Translation
5.     Chromosome structure
6.     Extrachromosomal structure (e.g., phage, plasmid, mitochondrial)
7.     Protein structure
C.    Biochemical Reagents
1.     Polymerase enzymes
a)     DNA
b)    RNA
2.     Endo and exonuclease enzymes
3.     Reverse transcriptase
4.     DNA ligase
5.     Assay development and design
D.   Genetics
1.     Human
2.     Microbial

                      II.         MOLECULAR TECHNIQUES (20-30%)
A.   Separation and Detection
1.      Electrophoresis
a)     Gel (including agarose acrylamide and
b)    pulsed field)
c)     Capillary
2.     Blotting and probing procedures (including washing and stringency)
3.     Probe hybridization
4.     Nucleic acid purification
5.      Probe structure (e.g., TaqMan, FRET, simple, beacon, scorpion)
B.    Nucleic Acid Amplification
1.     Polymerase chain reaction (PCR)
2.     PCR variations (e.g., real-time, nested, multiplex, arrays, reverse transcriptase)
3.     Branched DNA (bDNA) technology
4.     Sequence based (NASBA)
5.     Transcription-mediated technology (TMA)
6.     Strand displacement amplification (SDA)
7.     Loop-mediated isothermal amplification (LAMP)
8.     Other (e.g., hybrid capture, ligase chain reaction, cleavase)
C.    DNA Sequence Analysis
1.     Sanger Sequencing (e.g., chain terminators)
3.     Automated sequence analyzer
4.     Other (e.g., pyrosequencing)
D.   Other Techniques
1.     Denaturing HPLC
2.     Melt curves analysis
3.     Nucleic acid labeling
4.     in-situ hybridization (ISH)
5.     Restriction fragment length polymorphism (RFLP)
6.     Epigenetic modification
7.     Array technology (e.g., bead, microarray)
8.     Multiplex ligation-dependent probe  amplification (MLPA)
9.     Mass spectrophotometry

                    III.         LABORATORYOPERATIONS(15-25%)
A.   Contamination (e.g., biological, amplified and non-amplified nucleic acid)
1.     Prevention
2.     Monitoring and detection
3.     Elimination
B.    Quality Assurance
1.     A.  Specimen collection, preparation, transport and storage
a)     Evaluate quality and quantity of specimen
b)    Evaluate quality and quantity of nucleic acid
2.     Reagent selection, preparation (including calculations), storage, and disposal
3.     Assay selection and validation
4.     Result calculation, interpretation and reporting
5.     Quality control and proficiency testing
a)     Assay controls
b)    Proficiency testing
6.     Equipment and Instrumentation – principles, calibration, maintenance, troubleshooting and validation
C.    Guidelines and Regulations
1.     Test System Categories: Analyte specific reagent (ASR), research use only (RUO), in- vitro diagnostics (IVD) and lab developed tests (LDT)
2.     Regulations and Standards: CLIA, The Joint Commission, CAP, CMS, CLSI, FDA
D.   Personnel
1.     Continuing education
2.     Competency
E.    Safety

                    IV.         APPLICATIONS OF MOLECULAR TESTING (25-30%)
A.   Infectious Disease
1.      Qualitative Analysis (e.g., MRSA, C. difficile, respiratory pathogens, STD)
2.     Quantitative Analysis (e.g., viral load)
3.     Genotypic Characterization (e.g., molecular epidemiology, viral typing, resistance testing)
B.    Oncology
1.     Leukemias/Lymphomas (e.g., CML, ALL, translocations, clonal rearrangements)
2.     Solid Tumors
3.     Hereditary cancer syndromes (e.g., breast, colon, ovarian)
C.    Genetics
1.     Hemoglobinopathies (e.g., thalassemias, sickle cell anemias)
2.     Coagulopathies (e.g., Factor V Leiden, prothrombin, MTHFR)
3.     Trinucleotide repeat disorders (e.g., Fragile X, Huntington, muscular dystrophy)
4.     Single gene disorders (e.g., cystic fibrosis, Gaucher, hereditary hemochromatosis)
5.     Epigenetic disorders (e.g., Prader-Willi, Angelman)
D.   Other
1.     Histocompatibility
2.     Genetic identity (e.g., parentage, specimen identification, forensic)
3.     Engraftment
4.     Pharmocogenomics (e.g. HerceptinR, warfarin, PlavixR, carbemazepine)

No comments:

Post a Comment